GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...
Univar Solutions LLC announced on February 24, 2026 that its Ingredients + Specialties from Univar Solutions division has been appointed as the distributor for Ingredion Pharma Solutions, creating an ...
In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...
In this forward-looking whitepaper, Blue Mountain explores how agentic AI —autonomous, context-aware AI agents—could ...
Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...
A structured pathway supports individualized RNA-based and genome-editing therapeutics when ultra-rare prevalence precludes ...
Using patent intelligence data from the FounderNest platform, Gonzalez highlights where small-molecule synthesis, formulation ...
A: No new regulations were published in 2025 specific to data integrity. The evolving global regulatory systems do, however, ...
The rapid pace of digitalization has created a skills gap, necessitating that staff with traditional chemistry or biology ...
In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...
Eli Lilly has rolled out a multi-dose KwikPen version of tirzepatide, marketed as Zepbound, for chronic weight management—signaling a packaging update for one of the obesity market’s fastest-expanding ...
Tevard Biosciences, joining the leadership team in 2025 to spearhead the company’s pioneering tRNA-based gene therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results